We are live on ! Find out more
INMB icon

INmune Bio
INMB

48 hedge funds and large institutions have $26M invested in INmune Bio in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

79% more capital invested

Capital invested by funds: $14.5M → $26M (+$11.5M)

76% more call options, than puts

Call options by funds: $645K | Put options by funds: $367K

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

30% more funds holding

Funds holding: 37 → 48 (+11)

0.95% more ownership

Funds ownership: 11.85% → 12.8% (+0.95%)

Holders
48
Holders Change
+11
Holders Change %
+29.73%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
14
Reduced
9
Closed
3
Calls
$645K
Puts
$367K
Net Calls
+$278K
Net Calls Change
+$436K

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$362K
2
Citigroup
Citigroup
New York
+$301K
3
LNWTC
Laird Norton Wetherby Trust Company
Washington
+$264K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$247K
5
BlackRock
BlackRock
New York
+$210K

Top Sellers

Rank Fund Capital Flow
1
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$782K
2
Group One Trading
Group One Trading
Illinois
-$366K
3
FA
Fermata Advisors
California
-$229K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$125K
5
Simplex Trading
Simplex Trading
Illinois
-$83.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.1M -$77.5K -9,251 -2%
BlackRock
2
BlackRock
New York
$2.9M +$210K +25,105 +11%
RPAM
3
Rhenman & Partners Asset Management
Sweden
$2.01M – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.91M +$24.6K +2,937 +2%
Janney Montgomery Scott
5
Janney Montgomery Scott
Pennsylvania
$1.84M -$782K -93,328 -36%
Deutsche Bank
6
Deutsche Bank
Germany
$1.24M – – –
MCM
7
MAI Capital Management
Ohio
$1.1M +$5.05K +602 +0.6%
QCG
8
Quadrant Capital Group
Ohio
$676K – – –
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$651K -$125K -14,892 -20%
State Street
10
State Street
Massachusetts
$507K +$838 +100 +0.2%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$494K +$101K +11,995 +38%
UBS Group
12
UBS Group
Switzerland
$487K +$11.4K +1,365 +3%
Jane Street
13
Jane Street
New York
$486K +$362K +43,134 New
WIM
14
Westside Investment Management
California
$471K +$2.72K +325 +0.8%
Citigroup
15
Citigroup
New York
$404K +$301K +35,900 New
Citadel Advisors
16
Citadel Advisors
Florida
$381K +$164K +19,596 +137%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$376K +$4.27K +509 +2%
LNWTC
18
Laird Norton Wetherby Trust Company
Washington
$355K +$264K +31,500 New
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
$331K +$247K +29,437 New
FA
20
Fermata Advisors
California
$331K -$229K -27,276 -48%
Morgan Stanley
21
Morgan Stanley
New York
$288K +$180K +21,525 +527%
Northern Trust
22
Northern Trust
Illinois
$282K +$40.2K +4,799 +24%
Millennium Management
23
Millennium Management
New York
$273K +$203K +24,204 New
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$262K +$195K +23,258 New
6CM
25
683 Capital Management
New York
$217K +$161K +19,253 New
1
2 3

INMB Hedge Fund Activity: Q4 2023 in Review

48 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q4 2023, worth a combined $26M — up 79% from $14.5M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new INMB positions and 3 closed out — a net gain of 11 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $362K. The largest seller was Janney Montgomery Scott, cutting an estimated $782K.

  • 48 institutional investors held INmune Bio (INMB) as of Q4 2023, up from 37 in Q3 2023.
  • Funds reported $26M of INmune Bio stock for Q4 2023, up 79% quarter-over-quarter.
  • 14 funds opened new INmune Bio positions in Q4 2023 and 3 closed out, a net change of +11 holders.
  • The largest INmune Bio buyer in Q4 2023 was Jane Street, an estimated $362K added.
  • The largest INmune Bio seller in Q4 2023 was Janney Montgomery Scott, an estimated $782K sold.

Based on aggregated 13F filings for Q4 2023.